CFAP99
gene geneOn this page
Summary
CFAP99 (cilia and flagella associated protein 99, HGNC:51180) is a protein-coding gene on chromosome 4p16.3, encoding Cilia- and flagella-associated protein 99 (D6REC4).
Predicted to be located in motile cilium.
Source: NCBI Gene 402160 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 165 total
- MANE Select transcript:
NM_001193282
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51180 |
| Approved symbol | CFAP99 |
| Name | cilia and flagella associated protein 99 |
| Location | 4p16.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000206113 |
| Ensembl biotype | protein_coding |
| Entrez | 402160 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding_CDS_not_defined, 2 protein_coding
ENST00000382849, ENST00000511731, ENST00000514556, ENST00000515732, ENST00000635017, ENST00000860043
RefSeq mRNA: 1 — MANE Select: NM_001193282
NM_001193282
Canonical transcript exons
ENST00000635017 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001493543 | 2418955 | 2419093 |
| ENSE00003738843 | 2426459 | 2426586 |
| ENSE00003789015 | 2462443 | 2462605 |
| ENSE00003792081 | 2452142 | 2452346 |
| ENSE00003792527 | 2460037 | 2460242 |
| ENSE00003792697 | 2458723 | 2458864 |
| ENSE00003793187 | 2449934 | 2450005 |
| ENSE00003793409 | 2450947 | 2451018 |
| ENSE00003795990 | 2459107 | 2459258 |
| ENSE00003796244 | 2436874 | 2437018 |
| ENSE00003796528 | 2449670 | 2449750 |
| ENSE00003798378 | 2438070 | 2438164 |
| ENSE00003798605 | 2451264 | 2451352 |
| ENSE00003799959 | 2443130 | 2443242 |
| ENSE00003800347 | 2445131 | 2445308 |
| ENSE00004015273 | 2462810 | 2463002 |
Expression profiles
Bgee: expression breadth ubiquitous, 142 present calls, max score 93.50.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5229 / max 98.7876, expressed in 191 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 46610 | 0.5165 | 189 |
| 46613 | 0.0063 | 2 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 93.50 | gold quality |
| left testis | UBERON:0004533 | 88.46 | gold quality |
| right testis | UBERON:0004534 | 87.63 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.39 | gold quality |
| testis | UBERON:0000473 | 84.53 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.41 | gold quality |
| right adrenal gland | UBERON:0001233 | 72.28 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 72.10 | gold quality |
| left adrenal gland | UBERON:0001234 | 71.96 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 71.60 | gold quality |
| adrenal cortex | UBERON:0001235 | 69.78 | gold quality |
| adenohypophysis | UBERON:0002196 | 69.44 | gold quality |
| pituitary gland | UBERON:0000007 | 69.36 | gold quality |
| adrenal gland | UBERON:0002369 | 68.17 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 66.72 | gold quality |
| right lung | UBERON:0002167 | 66.45 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 66.38 | gold quality |
| cerebellar cortex | UBERON:0002129 | 66.20 | gold quality |
| left uterine tube | UBERON:0001303 | 65.67 | gold quality |
| cerebellum | UBERON:0002037 | 64.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 63.43 | gold quality |
| caudate nucleus | UBERON:0001873 | 62.65 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 62.51 | gold quality |
| hypothalamus | UBERON:0001898 | 62.40 | gold quality |
| nucleus accumbens | UBERON:0001882 | 62.09 | gold quality |
| right frontal lobe | UBERON:0002810 | 60.91 | gold quality |
| adrenal tissue | UBERON:0018303 | 60.52 | gold quality |
| fallopian tube | UBERON:0003889 | 60.28 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 60.28 | gold quality |
| metanephros cortex | UBERON:0010533 | 60.10 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.40 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap99 | ENSDARG00000097485 |
| mus_musculus | Cfap99 | ENSMUSG00000109572 |
| rattus_norvegicus | Cfap99 | ENSRNOG00000058434 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 99 — D6REC4 (reviewed: D6REC4)
All UniProt accessions (1): D6REC4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell projection. Cilium. Flagellum.
Similarity. Belongs to the CFAP99 family.
RefSeq proteins (1): NP_001180211* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039341 | CFAP99 | Family |
UniProt features (6 total): region of interest 2, coiled-coil region 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-D6REC4-F1 | 77.28 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 28 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, chr4p16, GOCC_MOTILE_CILIUM, GOCC_CILIUM, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CBX7_TARGET_GENES, E2F5_TARGET_GENES, FOXJ2_TARGET_GENES, FOXN3_TARGET_GENES, SNAI1_TARGET_GENES, TAFAZZIN_TARGET_GENES, ZNF175_TARGET_GENES, ZNF197_TARGET_GENES, ZNF589_TARGET_GENES, ZNF592_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (3): motile cilium (GO:0031514), cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cilium | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
426 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP99 | RSPH10B | P0C881 | 594 |
| CFAP99 | FARP2 | O94887 | 561 |
| CFAP99 | SSNA1 | O43805 | 547 |
| CFAP99 | PANK4 | Q9NVE7 | 528 |
| CFAP99 | ANKRD7 | Q92527 | 527 |
| CFAP99 | CFAP47 | Q6ZTR5 | 520 |
| CFAP99 | LRGUK | Q96M69 | 495 |
| CFAP99 | FAM227B | Q96M60 | 480 |
| CFAP99 | ABCF3 | Q9NUQ8 | 475 |
| CFAP99 | CFAP70 | Q5T0N1 | 460 |
| CFAP99 | CCDC180 | Q9P1Z9 | 447 |
| CFAP99 | CCDC70 | Q6NSX1 | 445 |
| CFAP99 | CFAP65 | Q6ZU64 | 445 |
| CFAP99 | SPATA17 | Q96L03 | 435 |
| CFAP99 | UBE2G1 | P62253 | 423 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A087WRI3, A2BFC9, A2RRW4, A4QMS7, A6NJV1, A6NL82, A6QPC0, A6QQ68, A8E4X8, A8E5W8, A8QW39, A9JS51, D6REC4, F1P3Y5, G3X6E2, P0C875, Q0VB26, Q1MSJ5, Q2IA00, Q2T9Q3, Q2TA11, Q3UY96, Q494V2, Q497Q6, Q4KKZ1, Q4QR77, Q4R5Y0, Q4R8V8, Q5NC57, Q5ZIH9, Q6J272, Q6PII3, Q6ZQR2, Q6ZVS7, Q7Z4T9, Q8CFW7, Q8N1D5, Q8N6G2, Q8WW14, Q95LR0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
165 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 158 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3389 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:2426693:ATG:A | acceptor_gain | 1.0000 |
| 4:2426693:ATGG:A | acceptor_gain | 1.0000 |
| 4:2437015:GAGG:G | donor_gain | 1.0000 |
| 4:2437017:GG:G | donor_gain | 1.0000 |
| 4:2437018:GG:G | donor_gain | 1.0000 |
| 4:2437019:G:GG | donor_gain | 1.0000 |
| 4:2437019:GTA:G | donor_loss | 1.0000 |
| 4:2437020:T:A | donor_loss | 1.0000 |
| 4:2438068:A:AG | acceptor_gain | 1.0000 |
| 4:2438068:AGT:A | acceptor_gain | 1.0000 |
| 4:2438069:G:GA | acceptor_gain | 1.0000 |
| 4:2438069:GT:G | acceptor_gain | 1.0000 |
| 4:2438069:GTG:G | acceptor_gain | 1.0000 |
| 4:2438161:CAAGG:C | donor_loss | 1.0000 |
| 4:2438163:AGGTG:A | donor_loss | 1.0000 |
| 4:2438164:GGTGA:G | donor_loss | 1.0000 |
| 4:2438165:GTG:G | donor_loss | 1.0000 |
| 4:2443239:TGAGG:T | donor_loss | 1.0000 |
| 4:2443243:G:GA | donor_loss | 1.0000 |
| 4:2443244:T:A | donor_loss | 1.0000 |
| 4:2449660:A:AG | acceptor_gain | 1.0000 |
| 4:2449661:C:G | acceptor_gain | 1.0000 |
| 4:2449747:CGAG:C | donor_loss | 1.0000 |
| 4:2449749:AGGT:A | donor_loss | 1.0000 |
| 4:2449751:GTGAG:G | donor_loss | 1.0000 |
| 4:2449752:T:A | donor_loss | 1.0000 |
| 4:2451406:A:T | donor_gain | 1.0000 |
| 4:2452139:CA:C | acceptor_loss | 1.0000 |
| 4:2452140:A:AG | acceptor_gain | 1.0000 |
| 4:2452140:AG:A | acceptor_gain | 1.0000 |
AlphaMissense
4594 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000011008 (4:2419669 G>A,C), RS1000059398 (4:2462413 T>G), RS1000064899 (4:2442481 G>C), RS1000081716 (4:2429691 A>C,G), RS1000111453 (4:2462198 A>G), RS10001516 (4:2453935 T>C,G), RS1000171834 (4:2422949 G>A), RS1000174293 (4:2426466 C>T), RS1000188101 (4:2460983 C>T), RS1000309431 (4:2423175 T>C), RS1000331113 (4:2431379 A>T), RS1000338792 (4:2432810 G>C,T), RS1000409639 (4:2460810 C>T), RS1000464486 (4:2460879 C>T), RS1000493401 (4:2427956 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004077_7 | Cognitive function | 1.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| licochalcone B | increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Methotrexate | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.